FDA Drug Recalls

Recalls / Class II

Class IID-0593-2017

Product

LIDOCAINE CREAM in all strengths including: 5%, 8%, 23%, 30%, LIDOCAINE / PRILOCAINE / MELYLEPHRINE 15% / 5% / 0.5% CREAM, LIDOCAINE / PRILOCAINE / MELYLEPHRINE 15% / 5% / 0.5% OINTMENT LIDOCAINE 23%/ TETRACAINE 7% CREAM, LIDOCAINE 23%/TETRACAINE 7% OINTMENT, LIDOCAINE 23%/TETRACAINE 7%/PRILOCAONE 2.5%, LIDOCAINE 24%/PRILOCAINE 26% OINTMENT, LIDOCAINE 30%/TETRACAINE 4% /PRILOCAINE 2%, LIDOCAINE 30%/PHENYLEPHRINE 0.25%, LIDOCAINE 30%/ TETRACAINE 10%, MELYLEPHRINE 4%, LIDOCAINE 30%/TETRACAINE 4%/PRILOCAINE, LIDOCAINE 7%/TETRACAINE 7% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

Affected lot / code info
All Lots

Why it was recalled

Lack of Assurance of Sterility: There are also CGMP Deviations.

Recalling firm

Firm
Synergy Rx
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
4901 Morena Blvd Ste 504A, N/A, San Diego, California 92117-7310

Distribution

Quantity
N/A
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2017-02-10
FDA classified
2017-03-15
Posted by FDA
2017-03-22
Terminated
2017-05-23
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0593-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls